Cargando…

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models

Parkinson's disease (PD) is a progressive, neurodegenerative disorder characterized by motor and non-motor symptoms. To date, no specific treatment to halt disease progression is available, only medication to alleviate symptoms can be prescribed. The main pathological hallmark of PD is the deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spathopoulou, Angeliki, Edenhofer, Frank, Fellner, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821105/ https://www.ncbi.nlm.nih.gov/pubmed/35145469 http://dx.doi.org/10.3389/fneur.2021.786835

Ejemplares similares

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
por: Devine, Michael J., et al.
Publicado: (2011)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Optimization of the Detection Method for Phosphorylated α-Synuclein in Parkinson Disease by Skin Biopsy
por: Liu, Xiaojing, et al.
Publicado: (2020)

A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism
por: Book, Adam, et al.
Publicado: (2018)

Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy
por: Fellner, Lisa, et al.
Publicado: (2020)

Differential Diagnosis of Multiple System Atrophy-Parkinsonism and Parkinson's Disease Using α-Synuclein and External Anal Sphincter Electromyography
por: Cao, Zhentang, et al.
Publicado: (2020)

Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease
por: Moudio, Serge, et al.
Publicado: (2022)

Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis
por: Eusebi, Paolo, et al.
Publicado: (2016)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
por: White, Alice J., et al.
Publicado: (2018)

Autophagy in α-Synucleinopathies—An Overstrained System
por: Fellner, Lisa, et al.
Publicado: (2021)

Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
por: Koh, Yong Hui, et al.
Publicado: (2018)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
por: Scott, Kirsten M., et al.
Publicado: (2018)

Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene
por: Doppler, Kathrin, et al.
Publicado: (2018)

Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson’s disease
por: Yu, Zhenwei, et al.
Publicado: (2023)

Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment
por: Fernández-Susavila, Héctor, et al.
Publicado: (2019)

Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
por: Javed, Hayate, et al.
Publicado: (2019)

Patient-specific pluripotent stem cell-based Parkinson’s disease models showing endogenous alpha-synuclein aggregation
por: Oh, Yohan
Publicado: (2019)

Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson’s Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology
por: Diao, Xiaojun, et al.
Publicado: (2021)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
por: Wang, Min S, et al.
Publicado: (2010)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
por: Tatenhorst, Lars, et al.
Publicado: (2016)

α-synuclein pathogenesis in hiPSC models of Parkinson’s disease
por: Baena-Montes, Jara M., et al.
Publicado: (2021)

Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells
por: Oliveira, L M A, et al.
Publicado: (2015)

Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson’s disease using electrophysiological measurements of visual processing
por: Østergaard, Freja Gam, et al.
Publicado: (2020)

Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications
por: Bell, Rosie, et al.
Publicado: (2021)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
por: Byers, Blake, et al.
Publicado: (2012)

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
por: Kang, Ji-feng, et al.
Publicado: (2016)

Using induced pluripotent stem cells for modeling Parkinson’s disease
por: Ke, Minjing, et al.
Publicado: (2019)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lt4l5sdlhj52ct6m93ksf9rq6s